Call Us: (1) 608 441-2729 - Email Us info@flugen.com

Twitter

M2SR: The Vaccine
Influenza
Leadership
Investors
News
Contact
- Contact
- Careers

Paul

News

M2sr Vaccine Technology: How Flugen Is Introducing New Solutions and Strategies for Influenza and COVID-19 Protection
Dual defense: FluGen’s M2SR vaccine shields against influenza and COVID-19
FluGen Announces Completion of First Cohort in Age De-escalation Clinical Trial of M2SR Flu Vaccine Candidate in Pediatric Subjects Ages 6 Months to 17 Years

FluGen, Inc.

597 Science Drive, Madison, WI 53711 Phone: 608-441-2729 Fax: 608-260-7704 E-Mail: info@flugen.com Web: www.flugen.com

source of article
Tweets by FluGenInc

FCOI Policy

(c)2016 FluGen, Inc. All rights reserved.

Twitter

FCOI policy